1. Home
  2. GOVX vs NCPL Comparison

GOVX vs NCPL Comparison

Compare GOVX & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$0.80

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

NCPL

Netcapital Inc.

HOLD

Current Price

$0.42

Market Cap

3.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOVX
NCPL
Founded
2001
1984
Country
United States
United States
Employees
19
20
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GOVX
NCPL
Price
$0.80
$0.42
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
201.0K
48.6K
Earning Date
04-15-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$739.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.31
52 Week High
$4.40
$2.87

Technical Indicators

Market Signals
Indicator
GOVX
NCPL
Relative Strength Index (RSI) 40.83 40.64
Support Level $0.64 $0.40
Resistance Level $2.00 $0.45
Average True Range (ATR) 0.09 0.04
MACD 0.02 0.01
Stochastic Oscillator 42.26 45.67

Price Performance

Historical Comparison
GOVX
NCPL

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: